Mexico’s competition authority is re-examining a major pharmaceutical merger, after the Panama Papers revealed the purchase had allegedly been funded by the wife of the owner of its biggest rival.
Open Source Content Management Mexico’s competition authority is re-examining a major pharmaceutical merger, after the Panama Papers revealed the purchase had allegedly been funded by the wife of the owner of its biggest rival.